Published in J Neurol Sci on August 15, 2001
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Mouse models of diabetic neuropathy. Neurobiol Dis (2007) 1.76
Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care (2009) 1.49
Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans. Diabetes Care (2010) 1.09
Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Investig (2011) 1.03
Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. Acad Radiol (2012) 0.97
Mouse models of diabetic neuropathy. ILAR J (2014) 0.84
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy. Arch Med Sci (2014) 0.78
Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial. Neurosciences (Riyadh) (2014) 0.75
Foot deformity in charcot marie tooth disease according to disease severity. Ann Rehabil Med (2011) 0.75
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Procedures for comparing samples with multiple endpoints. Biometrics (1984) 6.70
Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes (1970) 6.68
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care (1994) 5.02
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci (1984) 4.87
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
The clinical features of hereditary motor and sensory neuropathy types I and II. Brain (1980) 4.79
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia (2005) 4.61
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Natural history of brachial plexus neuropathy. Report on 99 patients. Arch Neurol (1972) 4.45
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34
Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology (2008) 4.31
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry (1976) 4.13
The mechanism of placebo analgesia. Lancet (1978) 4.10
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Changes due to age in internodal length in the sural nerve in man. J Neurol Neurosurg Psychiatry (1966) 3.96
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc (1991) 3.88
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol (1968) 3.80
Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatry (1979) 3.74
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med (2000) 3.57
Designs for group sequential tests. Control Clin Trials (1984) 3.56
Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol (1968) 3.48
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc (1971) 3.35
Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol (1981) 3.30
Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med (1991) 3.29
Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09
Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07
Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc (1975) 3.01
Polyneuropathy associated with hypothyroidism. J Neuropathol Exp Neurol (1970) 2.95
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc (1976) 2.93
Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology (1993) 2.92
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol (1983) 2.90
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol (1992) 2.80
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun (1981) 2.76
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol (1980) 2.75
The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A (2001) 2.71
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology (1998) 2.70
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest (1989) 2.69
Inclusion body myositis and myopathies. Ann Neurol (1995) 2.68
Utility of thermography in the diagnosis of lumbosacral radiculopathy. Neurology (1991) 2.66
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc (1995) 2.65
Endogenous pain control mechanisms: review and hypothesis. Ann Neurol (1978) 2.63
Manual motor performance in a deafferented man. Brain (1982) 2.63
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol (1997) 2.60
Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol (1991) 2.59
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care (2001) 2.57
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA (2001) 2.53
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet (2000) 2.47
Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology (2000) 2.46
Peripheral nerve function in sepsis and multiple organ failure. Chest (1991) 2.46
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab (1982) 2.45